Nasopharyngeal Carcinoma — Trials

Nasopharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 246
Recruiting: 131
Ph III recruiting: 54
Growth YoY: +5.4%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 22.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (35)

clinicaltrialsPublishedShowing 101–108 of 108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05652192	SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC	recruiting	Phase 2	37	Zhejiang Cancer HospitalOTHER	1	Dec 15, 2022	clinicaltrials
NCT05514275	Radiotherapy Combined With Endostatin and Capecitabine for NPC	recruiting	Phase 2	41	Zhejiang Cancer HospitalOTHER	1	Aug 24, 2022	clinicaltrials
NCT05397769